Freelance science journalist, covering drugs, clinical trials, biotech, pharma and more. Writes for Nature, The Lancet, The New Scientist, and others.

Search Tweets

Twitter Feed

@AsherMullard — 545 followers, 208 tweets

Jul 13, 2017

The Economics of Indication-Based Drug Pricing: higher drug utilization, higher overall spending, higher profits 

Jul 13, 2017

Time to move Alzheimer prevention trials even earlier in disease course, up to 25 years before onset, says Bateman 

Jul 06, 2017

RT @AndyBiotech: Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both  by FDA's Janet Wo…

Show more